Publications by authors named "Seyedeh Yasaman Alemohammad"
Article Synopsis
- Individuals with epilepsy have a higher prevalence of tobacco use, including cigarettes and electronic nicotine delivery systems (ENDS), compared to those without epilepsy.
- The study analyzed data from nearly 87,000 US adults, revealing that men and women with epilepsy were significantly more likely to engage in various forms of tobacco use.
- Factors such as sexual orientation, education level, and age were also found to influence tobacco use patterns among adults with epilepsy.
Article Synopsis
- Tobacco use, especially cigarettes and e-cigarettes, is linked to increased risks for individuals with weakened immune systems (WIS) in the US.
- Data analyzed from a large health survey revealed that a significant percentage of adults had WIS due to health conditions or prescriptions, with higher rates of current and former smokers among these individuals.
- The findings highlight the need for targeted interventions to reduce tobacco use in people with WIS, as they are particularly vulnerable to the adverse effects of smoking.
The COVID-19 virus, once a public health emergency, is now endemic. Immunization remains an important measure for mitigating high levels of disease, morbidity, and mortality related to COVID-19 infection. People with HIV (PWH), in particular, benefit from COVID-19 vaccination because of increased risk for severe COVID-19 infection.
View Article and Find Full Text PDFBackground: Smoking and vaping are linked to lung inflammation and lowered immune response.
Objective: Examine the prevalence of coronavirus disease 2019 (COVID-19) cases, testing, symptoms, and vaccine uptake, and associations with tobacco product use.
Methods: Data came from the 2021 National Health Interview Survey.
Background: Galectins are an eleven-member class of lectins in humans that function as immune response mediators and aberrancies in their expression are commonly associated with immunological diseases. Several studies have focused on galectins as they may represent an important biomarker and a therapeutic target in the fight against COVID-19. This systematic review and meta-analysis examined the usefulness of clinical assessment of circulating galectin levels in patients with COVID-19.
View Article and Find Full Text PDF